Gene activity app could reduce live model usage
Researchers have developed an app which displays the effects of diseases in mice models and can be accessed globally.
List view / Grid view
A drug target is anything within a living organism to which a drug is directed and/or binds, resulting in a change in its behaviour or function.
Researchers have developed an app which displays the effects of diseases in mice models and can be accessed globally.
Researchers have discovered that lung cancer cells metastasise using antioxidants, informing potential future therapies.
New research has revealed the immune cells may be critical in moving pathogenic fungal spores to the central nervous system, pointing to drug target.
A trial has begun in the US for the ENT-01 therapy treatment of Parkinson’s, with the first patient enrolled.
Researchers have used a new method to understand how antibiotics fight TB, which can guide future drug developments.
A new study found that betaine supplementations given to mice reduced schizophrenic behaviours, indicating a drug target.
A new study has identified a class of immune cells that respond to tuberculosis, indicating a drug target for the condition.
New research has identified an enzyme which causes degradation of dendritic spines, pointing to a drug target for Alzheimer’s.
Researchers have announced a humanised mouse model which can be used in drug development processes.
A study has discovered that a biomarker associated with pancreatitis is involved in its development to pancreatic cancer.
A new study has found an enzyme in the brains of mice models which induces Parkinson’s, suggesting future drug target.
A recent study has identified the DBC1 gene which leaves cancer cells more exposed to therapies.
A new study has shown that there are two populations of cells in the gut which leads to drug development potential.
Researchers have successfully created a multi-organ in vitro model to test toxicity and efficacy of drugs.
Researchers have found an enzyme and its counterpart which inhibit T-cells from attacking tumour cells.